​

Clover Health Investments (CLOV) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CLOV Stock Forecast

Clover Health Investments (CLOV) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $3.00, with a high of $3.00 and a low of $3.00. This represents a 51.52% increase from the last price of $1.98.

- $1 $2 $3 $4 $5 High: $3 Avg: $3 Low: $3 Last Closed Price: $1.98

CLOV Stock Rating

Clover Health Investments stock's rating consensus is Hold, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (11.11%), 5 Hold (55.56%), 3 Sell (33.33%), and 0 Strong Sell (0.00%).

Hold
Total 9 3 5 1 0 Strong Sell Sell Hold Buy Strong Buy

CLOV Price Target Upside V Benchmarks

TypeNameUpside
StockClover Health Investments51.52%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Plans Stocks29.69%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$3.00
Last Closing Price$1.98$1.98$1.98
Upside/Downside--51.52%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26-12--3
Feb, 26-12--3
Jan, 26-12--3
Dec, 25-12--3
Nov, 25-12--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 21, 2025Whit MayoLeerink Partners$3.00$2.922.74%51.52%
Dec 17, 2024Matt HewittCraig-Hallum$6.00$3.1689.87%203.03%
Aug 06, 2024Richard CloseCanaccord Genuity$2.50$1.8634.41%26.26%
Nov 16, 2022Citigroup$1.80$1.4425.00%-9.09%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 21, 2025Leerink PartnersMarket PerformMarket Performhold
Dec 17, 2024Craig-HallumBuyinitialise
Oct 07, 2024UBSNeutralinitialise
Aug 06, 2024Canaccord GenuityBuyBuyhold
Nov 16, 2022CitigroupNeutralNeutralhold
Aug 09, 2022CitigroupNeutralNeutralhold
May 10, 2022SVB LeerinkMarket PerformMarket Performhold
May 10, 2022Cowen & Co.Market PerformMarket Performhold
Feb 25, 2022SVB LeerinkMarket PerformMarket Performhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.25$-0.71$-0.45$-0.09$-0.17---
Avg Forecast$-1.15$-0.73$-0.42$-0.12$-0.14$-0.07$0.10$0.17
High Forecast$-1.15$-0.72$-0.40$-0.11$-0.13$0.05$0.10$0.18
Low Forecast$-1.16$-0.76$-0.44$-0.12$-0.15$-0.15$0.10$0.16
Surprise %8.70%-2.74%7.14%-25.00%21.43%---

Revenue Forecast

$1B $2B $2B $3B $3B $4B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.47B$1.10B$1.26B$1.37B$1.92B---
Avg Forecast$1.45B$3.37B$2.00B$1.38B$1.59B$1.88B$1.97B$2.17B
High Forecast$1.45B$3.46B$2.07B$1.43B$1.65B$1.88B$2.05B$2.25B
Low Forecast$1.45B$3.31B$1.95B$1.35B$1.55B$1.88B$1.89B$2.12B
Surprise %1.53%-67.44%-36.89%-0.72%21.08%---

Net Income Forecast

$-600M $-460M $-320M $-180M $-40M $100M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-587.76M$-339.57M$-213.36M$-43.01M$-85.55M---
Avg Forecast$-555.73M$-427.97M$-213.36M$-57.71M$-67.25M$-30.36M$48.67M$81.97M
High Forecast$-554.33M$-342.38M$-170.69M$-55.42M$-64.57M$24.11M$50.60M$86.03M
Low Forecast$-557.14M$-513.57M$-256.03M$-60.01M$-69.92M$-72.32M$46.73M$79.45M
Surprise %5.76%-20.66%--25.48%27.22%---

CLOV Forecast FAQ

Is Clover Health Investments stock a buy?

Clover Health Investments stock has a consensus rating of Hold, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 5 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Clover Health Investments is a neutral investment for most analysts.

What is Clover Health Investments's price target?

Clover Health Investments's price target, set by 9 Wall Street analysts, averages $3 over the next 12 months. The price target range spans from $3 at the low end to $3 at the high end, suggesting a potential 51.52% change from the previous closing price of $1.98.

How does Clover Health Investments stock forecast compare to its benchmarks?

Clover Health Investments's stock forecast shows a 51.52% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare plans stocks industry (29.69%).

What is the breakdown of analyst ratings for Clover Health Investments over the past three months?

  • March 2026: 0% Strong Buy, 33.33% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 0% Strong Buy, 33.33% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 0% Strong Buy, 33.33% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.

What is Clover Health Investments’s EPS forecast?

Clover Health Investments's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.07, marking a -58.82% decrease from the reported $-0.17 in 2025. Estimates for the following years are $0.1 in 2027, and $0.17 in 2028.

What is Clover Health Investments’s revenue forecast?

Clover Health Investments's average annual revenue forecast for its fiscal year ending in December 2026 is $1.88B, reflecting a -2.44% decrease from the reported $1.92B in 2025. The forecast for 2027 is $1.97B, and $2.17B for 2028.

What is Clover Health Investments’s net income forecast?

Clover Health Investments's net income forecast for the fiscal year ending in December 2026 stands at $-30.358M, representing a -64.51% decrease from the reported $-85.549M in 2025. Projections indicate $48.67M in 2027, and $81.97M in 2028.